Stimulation of Mucosal and Systemic Antibody Responses against Recombinant Transferrin-binding Protein B of <i>Actinobacillus pleuropneumoniae</i> with Chitosan after Tracheal Administration in Piglets

Abstract

This study evaluated the suitability of using a chitosan formulation as an adjuvant to enhance both the mucosal and systemic immune responses against recombinant transferrin-binding protein B (rTbp B) of Actinobacillus pleuropneumoniae via direct tracheal administration. The chitosan formulation was found to enhance mucosal immune response, as measured by the secretory IgA level in lung lavage fluid and lung homogenate extracts, and systemic immune response, as measured by the serum IgG level.

Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 改変禁止 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!